Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20091
20121
20142
20162
20171
20181
20191
20205
20213
20221
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed7
Active, not recruiting4
Terminated3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCAGY/ GINECO GROUP3
Eli Lilly and Company2
Regeneron Pharmaceuticals2
Aprea Therapeutics1
Arno Therapeutics1
Artios Pharma Ltd1
AstraZeneca1
BicycleTx Limited1
Centocor, Inc.1
Compugen Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms25
Endometrial Neoplasms12
Breast Neoplasms7
Colorectal Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Fallopian Tube Neoplasms4
Pancreatic Neoplasms4
Head and Neck Neoplasms3
Lung Neoplasms3
Neoplasm Metastasis3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.